Assignee
LA JOLLA INST ALLERGY & IMMUNOLOGY
US·21 granted patents·23 pending applications·16 citations·filing 2012–2023
Top patents by PatentIndex Score
44 records- 0194US9873744B1Methods of treating OX40 mediated recall immune responses using OX40L antibodies and agents useful for identifying sameLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2015·Granted Jan 23, 2018·8 cites·20 claims
- 0277US10774143B1Modulation of T cell signaling via slat association with IP3R1LA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2015·Granted Sep 15, 2020·2 cites·11 claims
- 0377US10703784B2Antigens and epitopes derived from Mycobacterium tuberculosisLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2012·Granted Jul 7, 2020·2 cites·6 claims
- 0472US10308689B2Dengue virus (DV) polypeptide sequences, T cell epitopes and methods and uses thereofLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2015·Granted Jun 4, 2019·2 cites·8 claims
- 0570US2023406947A1Light inhibitors for scleroderma and skin fibrotic disease treatmentLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2023·Application pending·0 cites
- 0668US12448433B2Human ApoB100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosisLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2021·Granted Oct 21, 2025·0 cites·13 claims
- 0767US11053297B2Monocyte modulation and control of tumor metastasisLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2016·Granted Jul 6, 2021·1 cites·12 claims
- 0865US2020369750A1Histamine-releasing factor (hrf), hrf-receptor and methods of modulating inflammationLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2019·Application pending·0 cites
- 0962US10428124B2Timothy grass allergens and methods and uses for immune response modulationLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2013·Granted Oct 1, 2019·1 cites·5 claims
- 1061US2021179725A1Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatmentLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2020·Application pending·0 cites
- 1160US10370438B2Histamine-releasing factor (HRF), HRF-receptor and methods of modulating inflammationLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2014·Granted Aug 6, 2019·0 cites·10 claims
- 1259US11806393B2Flavivirus peptide sequences, epitopes, and methods and uses thereofLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2019·Granted Nov 7, 2023·0 cites·11 claims
- 1357US10220081B2Methods of modulating HVEM, BTLA and CD160 cis complex response or signaling activity with soluble light polypeptide sequencesLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2014·Granted Mar 5, 2019·0 cites·11 claims
- 1456US10918713B2Epitopes from allergen proteins and methods and uses for immune response modulationLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2017·Granted Feb 16, 2021·0 cites·6 claims
- 1552US2021340218A1Monocyte modulation and control of tumor metastasisLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 1650US2017058037A1Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatmentLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2016·Application pending·0 cites
- 1749US11421006B2T cell epitopes from Cockroach and methods of making and using sameLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2013·Granted Aug 23, 2022·0 cites·11 claims
- 1848US11130798B2Human APOB100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosisLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2016·Granted Sep 28, 2021·0 cites·20 claims
- 1948US2018016345A1Light inhibitors for scleroderma and skin fibrotic disease treatmentLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2016·Application pending·0 cites
- 2047US2020224200A1Modulation of immune response through stimulator of interferon genesLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2018·Application pending·0 cites
- 2146US2019282580A1Pro-inflammatory role for adenosine uptake and metabolismLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2017·Application pending·0 cites
- 2246US2022241369A1Compositions and methods of modulating inflammationLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2019·Application pending·0 cites
- 2345US2020352999A1Use and production of engineered immune cells to disrupt nfat-ap1 pathway transcription factorsLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2018·Application pending·0 cites
- 2444US11951128B2Compositions and methods for the isolation and/or generation of specific CD4+ and CD8+ T-cell subsetsLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2018·Granted Apr 9, 2024·0 cites·8 claims
- 2544US10406218B2Specific and unique T cell responses and molecular signatures for the treatment and diagnosis of Mycobacterium tuberculosisLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2015·Granted Sep 10, 2019·0 cites·3 claims
- 2643US2016287696A1Pan pollen immunogens and methods and uses for immune response modulationLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2014·Application pending·0 cites
- 2741US2021015866A1Tissue resident memory cell profiles, and uses thereofLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2019·Application pending·0 cites
- 2841US2017088600A1Novel crystal structure and ligand binding sites of trail receptorLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2016·Application pending·0 cites
- 2941US2018335433A1Compositions targeting pkc-theta and uses and methods of treating pkc-theta pathologies, adverse immune responses and diseasesLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2018·Application pending·0 cites
- 3040US11331388B1PTP4A1 as a therapeutic target for fibrotic diseases and disorders including systemic sclerosisLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2016·Granted May 17, 2022·0 cites·15 claims
- 3139US10385340B2Autoimmune disease treatmentsLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2015·Granted Aug 20, 2019·0 cites·7 claims
- 3239US2018111991A1Modulators of activin and methods for modulating immune responses and t follicular helper cellsLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2017·Application pending·0 cites
- 3338US11505581B2Antigens and T cell epitopes from cockroach and methods of making and using sameLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2016·Granted Nov 22, 2022·0 cites·6 claims
- 3438US2020078401A1Compositions for cancer treatment and methods and uses for cancer treatment and prognosisLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2017·Application pending·0 cites
- 3538US2021145768A1Modulating immune response via targeting of olfactory receptor activityLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2019·Application pending·0 cites
- 3637US11547739B2Peptides and methods related to ICOS signalingLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2016·Granted Jan 10, 2023·0 cites·6 claims
- 3737US2018369330A1Methods and compositions using integrin-based therapeuticsLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2017·Application pending·0 cites
- 3837US2020216492A1Use of c-terminally extended peptides to disrupt inhibitor nk cell receptor interactions with mhc iLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2017·Application pending·0 cites
- 3936US10723750B2Sphingamide compounds and methods for binding iNKT cellsLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2016·Granted Jul 28, 2020·0 cites·16 claims
- 4036US2018120329A1Cxcl13 as an indicator of germinal activity and immune responseLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2016·Application pending·0 cites
- 4133US2022365091A1Intratumoral TFR Cells Curtail Anti-PD-1 Treatment EfficacyLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2020·Application pending·0 cites
- 4232US11517615B2Diagnosis and treatment of infection involving killer t follicular helper cells, methods of preparation, and uses thereofLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2018·Granted Dec 6, 2022·0 cites·14 claims
- 4329US2021088505A1Unipotent Neutrophil Progenitor Cells, Methods of Preparation, and Uses ThereofLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2018·Application pending·0 cites
- 4428US2018251533A1Methods and compositions for modulating monocyte populations and related uses thereofLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LA JOLLA INST ALLERGY & IMMUNOLOGY files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →